Global dermatology drugs market value was US$ 18.42 billion in 2022 and is forecast to reach a valuation of US$ 45.35 billion and 79.24 metric tons in terms of volume by 2031. The market is forecast to record a CAGR of 11.0% during the forecast period 2023-2031.
Request Sample Copy of Research Report @ https://www.astuteanalytica.com/request-sample/dermatology-drugs-market
About 85% of teenagers and young adults suffer from acne, the most prevalent skin disorder. Another common chronic skin disorder that affects 2-3% of people is psoriasis. In contrast, skin cancer is the 13th most prevalent type of cancer, with more than 2-3 million new instances of non-melanoma skin cancer and more than 132,000 new cases of melanoma identified annually. Despite the fact that there are numerous efficient treatments for various illnesses, there is still a significant unmet need for more efficient and secure treatments.
Dermatologists are optimistic that recent developments in biologics, immunotherapy and gene therapy will contribute to filling some of these unmet requirements. The U.S. holds a significant market share for dermatological medications worldwide, followed by Europe and Japan.
The dermatology drugs market is growing by the rising prevalence of skin diseases. The World Health Organization (WHO) said that currently an estimated 3.5 billion individuals worldwide are affected by skin disorders, a major rise in prevalence over the past few years. The need for dermatology drugs is likely to rise dramatically over the next few years as the world population will reach 9 billion people by the year 2050.
The industry expansion is also due to increasing skin health awareness and the availability of efficient treatments. Antifungals, corticosteroids, retinoids, antibiotics, and antihistamines are the most widely used topical medications. Immunosuppressants, biologics, and small-molecule therapies are examples of systemic agents. In addition, the nature and severity of the disease determine the best course of action.
Dermatology medications are subject to strict restrictions, and their costs are high may limit the global market expansion.
Dupixent, Humira, Enbrel, Remicade, Stelara, Cosentyx, Otezla, Taltz, Ilumya, and Eucrisa are some of the top brands. The top brand on the market is Dupixent. Adults with moderate-to-severe atopic dermatitis who are not properly responding to topical treatments can use the brand. The second-best-selling brand is Humira. A dermatology medication for moderate-to-severe plaque psoriasis is available for treatment with either phototherapy or systemic therapy in individuals with the disorder. The third most popular brand, Enbrel, is authorized to treat individuals with moderate-to-severe plaque psoriasis.
North America holds a substantial industry share. The U.S. and Canada are the two countries that use dermatology medications the most for a variety of reasons. First off, compared to other regions of the world, these nations have a higher prevalence of skin problems. Over 80% of people in the U.S. and Canada are said to have skin conditions, according to a World Health Organization survey.
Second, people have more discretionary cash to spend on products like dermatology treatment pharmaceuticals, or prescriptions because the standard of living in these nations is typically higher than in other areas of the world. Additionally, in North America, the healthcare systems are often more advanced and capable of facilitating reasonable access to dermatology treatments.
Lastly, compared to other parts of the world, the U.S. and Canada have significantly more sophisticated marketing and advertising strategies for dermatology medications. Pharmaceutical businesses make significant investments in promoting their goods in these nations, which increases demand for their goods.
Directly Purchase a copy of report with TOC @ https://www.astuteanalytica.com/inquire-before-purchase/dermatology-drugs-market
Drug Type Insights
In terms of drug type, the dermatology drugs industry bifurcates into branded prescription drugs, generic prescription drugs, and over-the-counter drugs (OTC). In 2022, the branded prescription drugs segment recorded a market share of 53.9%. Contrary, the over-the-counter drugs (OTC) segment will increase at the highest growth rate of 12.0%.
The majority of medications used in dermatology to treat skin infections, eczema, psoriasis, and acne can be found in a range of forms, such as creams, gels, lotions, ointments, and solutions. Some can be used on any body part, while others are made for specific body parts, such as the face or scalp. In addition, retinoids, corticosteroids, antifungals, keratolytic, and antibiotic, agents are the most common active components in dermatology drugs. Retinoids aid to unclog clogged pores and slow down cell turnover, while corticosteroids are utilized to decrease inflammation. Antibiotics help to treat infections caused by bacteria, while antifungals are used to treat infections caused by fungi. Keratolytic substances aid in removing buildup from the skin’s surface.
Therapeutic Application Insights
In terms of therapeutic application, the dermatology drugs industry divides into acne, dermatitis, psoriasis, rosacea, inflammatory dermatoses, and others. Dermatitis and Acne are the most popular application.
According to the investigation of acne prevalence and treatment, most people with acne are treated with topical medications, while only a tiny proportion take oral medications. Tetracyclines are the most frequently given oral drugs, while benzoyl peroxide and salicylic acid are the most widely used topical treatments for acne. Nearly 80% of acne sufferers are between the ages of 12 and 24, according to a survey of the worldwide dermatology drugs market. Teenagers and young adults have the highest prevalence of acne. Nearly 60% of sufferers with acne are female, making them more likely than men to get it.
Route of Administration Insights
On the basis of the route of administration, the global market classifies oral medicines, topical medicines, and parenteral medicines. Above all, the topical drugs segment held the maximum market share.
Corticosteroids, antibiotics, antifungals, and retinoids are the most popular classes of topical dermatologic medications. The most popular class of topical dermatologic medication is topical corticosteroids. Inflammatory skin diseases like eczema, psoriasis and allergic contact dermatitis can all be effectively treated with them. There are two categories of topical corticosteroids: first-generation and second-generation.
Topical corticosteroids of the first generation have more side effects compared to the second generation. As they are more effective and have fewer side effects, second-generation medications are typically favored over first-generation ones in the worldwide dermatology drug market. Antifungal drugs are used to treat skin fungal infections, such as ringworm, jock itch, and athlete’s foot. Antibiotic drugs are used to treat bacterial skin infections like cellulitis and acne. Acne, photoaging, and psoriasis are just a few of the disorders that are treated using retinoids, which are vitamin A derivatives.
By Drug Type
- Branded Prescription Drugs
- Generic Prescription Drugs
- Over-The-Counter Drugs (OTC)
- Other Formulations
By Route of Administration
- Oral Medicines
- Topical Medicines
- Parenteral Medicines
By Therapeutic Application
- Inflammatory dermatoses
By Distribution Channel
- Retail Channel
- Online Channel
- North America
- The U.S.
- Western Europe
- The UK
- Rest of Western Europe
- Eastern Europe
- Rest of Eastern Europe
- Asia Pacific
- Australia & New Zealand
- South Korea
- Rest Of ASEAN
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- Rest of MEA
- South America
- Rest of South America
To gain more insights into the market with a detailed table of content and figures, click here: https://www.astuteanalytica.com/industry-report/dermatology-drugs-market
About Astute Analytica
Astute Analytica is a global analytics and advisory company which has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.
BSI Business Park, H-15,Sector-63, Noida- 201301- India
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)
Follow US: LinkedIn | Twitter